{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:10:13Z","timestamp":1758474613827,"version":"3.32.0"},"reference-count":0,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.14.1403029err1","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:00:43Z","timestamp":1734638443000},"source":"Crossref","is-referenced-by-count":1,"title":["Erratum: Maffioli EM, Mont\u00e1s MC, Anyakora C. Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries. J Glob Health. 2024 Jun 7;14:03029."],"prefix":"10.7189","volume":"14","author":[{"name":"Journal of Global Health Editorial Team","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4223","published-online":{"date-parts":[[2024,12,20]]},"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2024\/jogh-14-1403029err1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:00:44Z","timestamp":1734638444000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2024\/jogh-14-1403029err1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7189\/jogh.14.1403029err1","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"article-number":"1403029err1"}}